Abstract
We here report three kindreds with a total of 19 persons affected with central and peripheral resistance to thyroid hormones: one kindred with 10 affected persons is the largest reported to date. Male to male transmission of the syndrome was evident in two kindreds, consistent with an autosomal dominant mode of inheritance. During several years of follow up, the degree of resistance to thyroid hormones did not ameliorate. Within a given kindred, a given tissue or tissues was consistently more resistant to thyroid hormone than other tissues. The pattern of tissues most affected in one kindred differed from that of another kindred, perhaps reflecting the inherited underlying molecular defects. Members of kindred A frequently had bone involvement, and several had learning disabilities and recurring infections, while most members of kindreds B and C had little bone involvement, but marked hepatic and cardiac resistance to thyroid hormones. Kinetic studies of the binding of [125I] triiodo-L-thyronine to nuclei from skin fibroblasts from affected patients from each of the kindreds demonstrated decreased maximum binding as compared to normal fibroblasts, but there was no correlation between this parameter and other features of the disease. Four of the 19 patients had previously been treated inappropriately with antithyroid therapies, demonstrating how the syndrome may be readily confused with Graves’ disease by some clinicians. Behavior or school performance improved in all children treated with thyroid hormones, and a growth spurt was documented in six children, but objective improvement in IQ scores was not demonstrated, suggesting that initiation of hormone therapy at an early age may be important for maximum benefit.
Similar content being viewed by others
References
Refetoff S., DeWind L.T., DeGroot L.J. Familial syndrome combining deaf-mutism, stippled epiphyses, goiter and abnormally high PBI: possible target organ refractoriness to thyroid hormone. J. Clin. Endocrinol. Metab. 27: 279, 1967.
Refetoff S. Syndrome of thyroid hormone resistance. Am. J. Physiol. 243: E88, 1982.
Gershengorn M.C., Weintraub B.D. Thyrotropin-induced hyperthyroidism caused by selective pituitary resistance to thyroid hormone: A new syndrome of “inappropriate secretion of TSH”. J. Clin. Invest. 56: 633, 1975.
Weintraub B.D., Gershengorn M.C., Kourides I.A., Fein H. Inappropriate secretion of thyroid-stimulating hormone. Ann. Intern. Med. 95: 339, 1981.
Kaplan M.M., Swartz S.L., Larsen P.R. Partial peripheral resistance to thyroid hormone. Am. J. Med. 70: 1115, 1981.
Liewendahl K. Triiodothyronine binding to lymphocytes from euthyroid subjects and a patient with peripheral resistance to thyroid hormone. Acta Endocrinol. (Kbh.) 83: 64, 1976.
Bernal J., Refetoff S., DeGroot L.J. Abnormalities of triiodothyronine binding to lymphocytes and fibroblast nuclei from a patient with peripheral tissue resistance to thyroid hormone action. J. Clin. Endocrinol. Metab. 47: 1266, 1978.
Daubresse J.-C., Dozin-VanRoye B., DeNayer P., De-Vischer M. Partial resistance to thyroid hormones: reduced affinity of lymphocyte nuclear receptors for T3 in two siblings. In: Stockigt J.R., Nagataki S. (Eds.), Thyroid research VIII. Australian Academy of Science, Canberra, 1980, p. 295.
Maxon H.R., Burman K.D., Premachandra B.N. Euthyroid, familial hyperthyroxinemia. N. Engl. J. Med. 302: 1263, 1980.
Elewaut A., DeBaets M., Vermeulen A. Triiodothyronine binding to lymphocyte nuclei and plasma cyclic AMP response to intravenous glucagon in patients with peripheral resistance to thyroid hormones. Acta Endocrinol. (Kbh.) 97: 54, 1981.
Cooper D.S., Ladenson P.W., Nisula B.C., Dunn J.F., Chapman E.M., Ridgway E.C. Familial thyroid hormone resistance. Metabolism 31: 504, 1982.
Liewendahl K., Rosengard S., Lamberg B.A. Nuclear binding of triiodothyronine and thyroxine in lymphocytes from subjects with hyperthyroidism, hypothyroidism and resistance to thyroid hormone. Clin. Chim. Acta 83: 41, 1978.
Maenpaa J., Liewendahl K. Peripheral insensitivity to thyroid hormones in a euthyroid girl with goiter. Arch. Dis. Child. 55: 207, 1980.
Chait A., Kanter R., Green W., Kenny M. Defective thyroid hormone action in fibroblasts cultured from subjects with the syndrome of resistance to thyroid hormone. J. Clin. Endocrinol. Metab. 54: 767, 1982.
Kaplowitz P.B., D’Ercole A.J., Utiger R.D. Peripheral resistance to thyroid hormone in an infant. J. Clin. Endocrinol. Metab. 53: 958, 1981.
Eil C., Fein H.G., Smith T.J., Furlanetto R.W., Bourgeois M., Stelling M.W., Weintraub B.D. Nuclear binding of [125I] triiodothyronine in dispersed cultured skin fibroblasts from patients with resistance to thyroid hormone. J. Clin. Endocrinol. Metab. 55: 502, 1982.
Bantle J.P., Seeling S., Mariash C.N., Ulstrom R.A., Oppenheimer J.H. Resistance to thyroid hormones: a disorder frequently confused with Graves’ Disease. Arch. Intern. Med. 142: 1867, 1982.
Wortsman J., Premachandra B.N., Williams K., Burman K., Hay I.D., Davis P.J. Familial resistance to thyroid hormone associated with decreased transport across the plasma membrane. Ann. Intern. Med. 98: 904, 1983.
Gheri R.G., Bianchi R., Mariani G., Toccafondi R., Cappelli G., Brat A., Borghi A., Giusti G., Forti G. A new case of familial partial generalized resistance to thyroid hormones: Study of 3,5,3′-triiodothyronine (T3) binding to lymphocyte and skin fibroblast nuclei and in vivo conversion of thyroxine to T3. J. Clin. Endocrinol. Metab. 58: 563, 1984.
Menezes-Ferreira M.M., Eil C., Wortsman J., Weintraub B.D. Decreased nuclear uptake of [125I] triiodo-L-thyronine in fibroblasts from patients with peripheral thyroid hormone resistance. J. Clin. Endocrinol. Metab. 59: 1081, 1984.
Nisula B.C., Dunn J.F. Measurement of the testosterone binding parameters for both testosterone-estradiol binding globulin and albumin in individual serum samples. Steroids 34: 771, 1979.
Brooks M.H., Barbato A.L., Collins S., Garbincius J., Neidballa R.G., Hoffman D. Familial thyroid hormone resistance. Am. J. Med. 71: 414, 1981.
Refetoff S., DeGroot L.J., Bernard B., DeWind L.T. Studies of a sibship with apparent hereditary resistance to the intracellular action of thyroid hormone. Metabolism 21: 723, 1972.
Refetoff S., Salazar A., Smith T.J, Scherberg N. The consequences of inappropriate treatment because of failure to recognize the syndrome of and peripheral tissue resistance to thyroid hormone. Metabolism 32: 822, 1983.
Mau G., Schnakenburg K.V. Maldescent of the testes-an epidemiological study. Eur. J. Pediatr. 126: 77, 1977.
Murata Y., Refetoff S., Horvitz A.L., Smith T.J. Hormonal regulation of glycosaminoglycan accumulation in fibroblasts from patients with resistance to thyroid hormone. J. Clin. Endocrinol. Metab. 57: 1233, 1983.
Bereu B.B., Haupt R., Johnsonbaugh R., Rodbard D. The pulse wave arrival time (QKd interval) in normal children. J. Pediatr. 95: 716, 1979.
Behrman R.E., Vaughan V.C. Nelson’s textbook of pediatrics (Appendix, Table 29-2, Reference ranges). W.B. Saunders, Philadelphia, 1983, p. 1832.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Magner, J.A., Petrick, P., Menezes-Ferreira, M.M. et al. Familial generalized resistance to thyroid hormones: report of three kindreds and correlation of patterns of affected tissues with the binding of [125I] triiodothyronine to fibroblast nuclei. J Endocrinol Invest 9, 459–470 (1986). https://doi.org/10.1007/BF03346968
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03346968